2004 16 27 18 521-529 2004 17 1 pp.103-109 2 22 725-732 3 XIV A. B. pp.234-239 4 1 47 1515-1526 5 2 47 1588-1595 6 47 1953-1961 7 XIV. C. pp.240-243 8 XIV. G. pp.251-252 9 XIV. I. pp.255-257 10 XIV. D. pp.243-246 11 XIV. E. pp.246-248 12 XIV. H. pp.253-254 13 One Point Advice 1 pp.78-79 14 pp.98-103 15 14 31
pp.736-742 16 14 pp.744-748 17 14 pp.764-768 18 01 80 pp.1-6 19 02 80 pp.7-11 20 03 80 pp.13-18 21 junior pp.19-28 22 junior pp.29-37 23 80 pp.39-48 24 12 80 pp.89-95 25 pp.23-39 26 2 pp.17-19 27 5 a. pp.55-61 28 4219 pp.27-32 29 76 347-351 30 NEW MOOK pp.1-6 31 59 142-148 1) NEWMOOK 9. 2) NEWMOOK 9. p23-29 32
3) NEWMOOK 9. p84-90 4) NEWMOOK 9. p98-109 5) NEWMOOK 9. p165-169 6) 132-133 7) p88-93 8) p50-52 9) PDT p92-93 10) QOL p136-137 11) p292-295 12) FA IA p96 13) p130 14) p136 15) p145 16) p148 17) RAP p156 18) p200-207 19) p218 20) 33
p224-231 21) p284 22) p164-167 23) 80 34
2004 16 25 c 63 446-449 2004 17 1 Kunimatsu S Tomita G Araie M Aihara M Suzuki Y Iwase A Koseki N Matsumoto S Yamazaki Y Yoshikawa K Frequency doubling technology and scanning laser tomography in eyes with generalized enlargement of optic disc cupping J Glaucoma 14 280-287 2) Ikeda A Sakimoto T Shoji J Sawa M Expression of - and - defensins in human ocular surface tissue Jpn J Ophthalmol 49 73-78 3) Shoji J Sakimoto T Muromoto K Inada N Sawa M Chisei Ra Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in Balb/c mice Jpn J Ophthalmol 49 205-210 4) Kamura Y Sato Y Isomae T Shimada H Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients Jpn J Ophthalmol 49 297-300 5) 22 677-681 6) 6 47 195-201 7) V Rock n Roll 47 995-999 8) 47 1283-1290 9) 47 1360-1380 10 47 2003-2008 11) 99 707-709 12 Uveal Effusion 1 56 45-49 35
13) IgE 2000 56 420-425 14) Primary position upbeat nystagmus 109 205-209 15) 109 267-273 16) 109 596-602 17) c -677 47 6-21 18) SEE-17 47 212-222 1) Shimada H, Mori R,Arai K, Kawamura A, Yuzawa M:Surgical excision of retinal angiomatous proliferation. Graefe's Arch Clin Exp Ophthalmol. vol243; 519-524,. 2) Shimada H, Nakashizuka H, Nakajima M, Mori R and Mizutani Y: Twenty-gauge transconjunctival vitrectomy, Jpn J Ophthalmol, Vol; 49: 257-260, 3) Shimada H, Fujita K, Matsumoto Y, Mori R, Yuzawa M: Surgical excision of type 2 choroidal neovascularization in age-related macular degeneration. Jpn J Ophthalmol. vol; 49:321-323, 4) Shimada H, Fujita K, Matsumoto Y, Mori R, Yuzawa M: Surgical excision of type 1+2 choroidal neovascularization in age-related macular degeneration. Jpn J Ophthalmol. vol49; 324-326,. 5) Shimada H, Nakashizuka H, Mori R and Mizutani Y: Expanded indications for 25-gauge transconjunctival vitrectomy, Jpn J Ophthalmol vol; 49: 397-401, 6) Suzukamo Y, Oshika T, Yuzawa M, Tokuda Y, Tomidokoro A, Oki K, Mangione CM Green J, Fukuhara S: Psychometric Properties of the 25-item National Eye Institute Visual Function Questionnaire(NFI VFQ-25), Japanese Version, Health and Quality of Life Outcomes, 3: 65-72, 7) 18 395-400. 8) 1 Capsular Block Syndrome 18 36
413-416 9) 109 83-87 10) 109 417-427 11) 59 1303-1306 12) QOL 41-43 13) QOL 16 37-40 3 14) Retinal angiomatous proliferation 16 96-101 3.. 15) 16 186-189 3. 16) 16 200-203 3. 17) preferred retinal locus 16 207-209 3. 37
2004 16 19) 18 521-529 2004 20 2004 58 2242-2246 2004 17 1 Short-wavelength automated perimetry; SWAP 47 278-292 2 58 47 481-483 3 Update 47 659-660 4 Update 47 703-708 5 Vogt- - 47 927-928 6 47 1167-1168 7 16. 47 1487-1495 8 II 47 1515-1526 9 II 47 1588-1595 10 Wegener 47 1746-1750 11 NTG 76 111-112 12 76 347-351 13 NTG 76 503-504 14 CL 76 645-646 15 59 142-148 16 No.25 1 Yuzawa M Summalises from Retina issue 2 Retina p3 38
2 22 613-620 3 41 6 4 56 298-300 5 56 463-466 6 47 1-17, 7 PDT 47 37~45, 8 2000 47 371-384 9 PCV/RAP 47 585-586 10 7 10 p10-14 11 QOL 18 331-335 12 190:17-23 13 Quality of Life 109 73-74 14 109:591-595 15 76 451 16 76 251-252 17 76 797-798 18 AMD 76 1057-1061 19 25 140 25 76 1073-1074. 39
17 1) Eye Bank Journal 9 3 26-27 2 58 574 54 1 PDT Ophthalmics MAGAZINE 2 2 40
2004 16 83 58 11.14 2004 17 1) 16 1.15 2) Kanai A, Nishida T, Itoi M, Watanabe K, Hamano T, Sawa M Japan Contact Lens Society (JCLS) Symposium. Contact lens & Eyecare Symposium, San Diego, California, USA, 1.22, 3) 16 1.27 4) Mitomycin MMC 28 1.28 5) 28 1.29 6) 76 2.3 7) IgA 29 21 2.17 8) 29 21 2.17 9) PCR 29 21 2.17 10) 29 21 2.17 11) Antibody array 29 21 2.17 12) 29 21 2.17 41
13) J1 IgE 29 21 2.18 14) c 29 21 2.19 15) 29 21 2.19 16) 15 2.26 17) 30 3.5 18) 3.23 19) CRVO 109 3.25 20) NTG 109 3.25 21) 109 3.26 22) Sawa M, Okajima Y, Saika S: The effects of surface modification by 2-methacryloyloxymethyl phosphorylcholine (MPC) IOL biocompatibility. (Session1-IOL material issues)icbro, Washington D.C., USA 4.15, 23) 4.21 24) Moraxella 15 4.22 25) I 27 4.24 26 TINU 49 4.20 27) Nakajima M, Yamazaki Y, Yamamoto M, Kawashima M: Evaluation of radial optic neurotomy for central retinal vein occlusion, a Color Doppler Imaging investigation. ARVO annual meeting, Fort Lauderdale, Florida, USA, 5.4, 28) 17 5.21 29) 10 Tokyo Ocular Surface 42
Forum 5.28 30) 77 6.2 31 Yoshio Yamazaki The effect of trabeculectomy on retrobulbar circulation in glaucoma patients. Kreitz-Drance Glaucoma Meeting, Vancouver, Canada, 6. 4, 32) 6.12 33) 44 20 6.17 34) MPC 44 20 6.18 35) 44 20 6.18 36) 44 20 6.18 37) 10 IVH 30 6.25 38 10 30 6.25 39) 6.25 40) 42 7.8 41) CVJ-18 48 7.9 42 42 7.9 43) 7 7.10 44) 743 7.13 45) 7.14 43
46 Yoshio Yamazaki The effect of trabeculectomy on retrobulbar circulation. Harbin Cataract Forum, Special Lecture, Harbin, China,. 8. 20 47) GD VCC, OCT HRT 16 9.16 48) glaucoma-like disc 16 9.16 49) c 59 10.7 50) B 59 10.7 51) 59 10.7 52) Eotaxin-1, 2, 3 59 10.7 53) c 59 10.7 54) 59 10.7 55) Foville 59 10.8 56) 59 10.8 57) Sawa M Study on clinical methods and their significance to investigate ocular surface disorders using tears 94 10.8 58) Sawa M Laser flare-cell photometer and its role in clinical study (Cataract update symposium) 94 10.8 59) NTG 59 10.9 60) 59 10.9 61) 1 14 59 10.10 44
62) 55 10.21 63 16 11.11 64) Fisher 43 11.12 65) 43 11.12 66) 11.18 67) NTG 11.19 68) Johoku Ophthalmic Club 11.25 69) 11.26 70) 44 12.2 71) 44 12.3 72 36 12.3 73 79 12.8 74) 79 12.8 1 1.16. 2 2004 1.21-22.2004 3 Retinal angiomatous proliferation 2004 1.21-22.2004 4 2004 1.21-22.2004 5 1 2004 1.21-22.2004 6 merg 45
2004 1.21-22.2004 7 2004 1.21-22.2004 8 preferential retinal locusn 2004 1.21-22.2004 9 28 1.28-30. 10 28 1.28-30. 11 28 1.28-30. 12 25G 28 1.28-30. 13 76 2.3. 14 76 2.3. 1576 2.3. 1676 2.3. 17 : Quality of life(qol) QOL 16 2.19 18 3.9.2004 19 PDT 3.12. 20 3.17. 21 109 3.24-27. 22 Retinal angiomatous proliferation 109 3.24-27. 23109 46
3.24-27. 24 : Quality of life(qol) 109 3.24-27. 25 : 109 3.24-27. 26 109 3.24-27. 27 ABCC6 109 3.24-27. 28 109 3.25. 29 3.31. 30 3.31. 31 19 4.9. 32 PDT 60 PDT 4.16. 33 106 4.17. 34 PDT 13 5.20 35 PDT 13 5.20 36 Uveal effusion 13 5.20 37 3 77 6.2. 38 Uveal effusion 77 6.2. 39 Pfizer Ophthalmic SC Conference 6.4. 40 Yuzawa M, Kawamura A, Nakata M: Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation, 8th 47
Michaelson Symposium, Ghent Belgium, 6.11. 41 Mori R. Kawamura A. Shimada H. Arai K. Nakata M. Haruyama M. Yuzawa M The retinal circulation after surgical disconnection of retinal angiomatous proliferation 8th Michaelson Symposium Gent. Belgium 6.11 42 EBM 50 7.2. 43 50 7.2 44 EBM 50 7.9. 45 50 7.9. 46 EBM 50 7.16. 47 50 7.16 48 22 7.23. 49 HRA Part 2 22 7.23. 50 ICG 22 7.23. 51 17 7.30. 52 25G Japan Macula Club 8.20-21.. 50 8.27. 53 50 8.27 54 Yuzawa M Present statue of photodynamic therapy for age-related macular degeneration in Japan, Photodynamic therapy (Symposium) 16th World Congress of the international society for Laser Surgery and Medicine(16th ISLSM) Tokyo 9.9. 55 9.10. 56 9.17. 57 17 9.24. 48
58 78 9.29 59 78 9.29 60 9.29. 61 59 10.7-10 62 59 10.7-10 63 20 25 59 10.7-10 64 ( ) ( ) 59 10.7-10 65 59 10.7-10 66 stage 3 RAP 59 10.7-10 67 59 10.7-10 68 ( ) ) ( ) ( ) NTT 59 10.7-10 6959 10.7-10 70 PDT 59 10.7-10 71 PDT 59 10.7-10 72 59 10.8. 73 21 10.15. 74 49
10.22. 75 745 10.27 76 10.29. 77 25G 25G 11.7.. 78 11.10. 79 11.11. 80 1/4 43 11.11 81 70 11.17. 82 14 11.18 83 14 11.18 84 17 11.19. 85 11.19. 86 : 22 11.20. 87 11.25. 88 11.26. 89 PDT 44 12.4. 90 PCV PDT 44 12.2-4 91 ( ) 44 12.2-4 92 44 12.2-4 93 44 12.2-4 50
94 PDT PDT 12.4 95, Aditya Kelkar, Jean-Jacques De Laey Ghent 79 12.8. 96 12.10. 51